De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making.
Saved in:
| Title: | De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making. |
|---|---|
| Authors: | Radfar N; Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA. nr435@njms.rutgers.edu., Gala D; Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA., Singh H; Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA., Bello J; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Allencherril J; Division of Cardiology, Department of Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, USA. |
| Source: | American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 Jun 23. Date of Electronic Publication: 2026 Jun 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
